Striverdi Respimat 2.5 mcg

Striverdi Respimat 2.5 mcg is a medicine authorised by Swissmedic under authorisation number 67399. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 May 2019 and the authorisation is valid without a time limit. ATC code R03AC19 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 67399
  • ATC R03AC19
  • Synthetic medicines
Authorisation data
Authorisation number67399
NameStriverdi Respimat 2.5 mcg
Full nameStriverdi Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)
Authorisation holderBoehringer Ingelheim (Schweiz) GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03AC19
First authorisation02 May 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Striverdi Respimat 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)B02 May 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11StückR03AC1903.04.3.B
23StückR03AC1903.04.3.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Striverdi Respimat 2.5 mcg authorised in Switzerland?

Yes. Striverdi Respimat 2.5 mcg is authorised by Swissmedic under authorisation number 67399, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Striverdi Respimat 2.5 mcg have?

Striverdi Respimat 2.5 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Striverdi Respimat 2.5 mcg?

The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com